Drug intelligence / Profile preview

chenopodium formosanum extract + fagopyrum esculentum extract

Development stage
Preclinical
Administration
Oral
01

Overview

A combination extract of **Chenopodium formosanum** (Djulis) and **Fagopyrum esculentum** (buckwheat) contains bioactive phytochemicals known for antioxidant, anti-inflammatory, hepatoprotective, anti-hyperglycemic, and potential anti-tumor effects. - **Chenopodium formosanum extract** is rich in polyphenols, flavonoids, and betalain pigments, demonstrating strong antioxidant activity, hepatoprotection (by modulating cytokines and antioxidant enzymes), inhibition of inflammatory pathways such as TLR4/NF-κB, and reduction in hyperglycemia and hyperlipidemia. - **Fagopyrum esculentum extract** (from seeds, leaves, or sprouts) contains significant levels of rutin and other flavonoids, offering anti-inflammatory, antioxidant, anti-hyperglycemic, and potential anti-tumor activities. It is used in traditional medicine for invigorating the spleen and combating inflammation, detoxification, and fever. No evidence indicates an established pharmaceutical product formed by combining both extracts, but both ingredients are well-studied as dietary supplements or nutraceuticals with overlapping mechanisms, including free radical scavenging, cytokine modulation, and metabolic support[1][2][3][4].

Other names
chenopodium formosanum extract + fagopyrum esculentum extract
02

Targets

MMP12 (Macrophage Metalloelastase)

Beyond the preview

Go deeper on chenopodium formosanum extract + fagopyrum esculentum extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chenopodium formosanum extract + fagopyrum esculentum extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call